Melanom
- Felles 002 Dakarbazin
- Felles 028, 074, 075, 076 Zoledronsyre
- Felles 036 Paklitaksel -21
- Felles 041 Nivolumab 3mg/kg
- Felles 048, 063 Pembrolizumab fast dose
- Felles 053, 054, 139 Nivolumab fast dose
- Felles 080 Ipilimumab 1 mg/kg / nivolumab 3mg/kg
- Felles 136ab MK-3475-587 Pembrolizumab
- Handlingsprogram Maligne melanomer
- Melanom 004 Ipilimumab
- Melanom 009 Nivolumab + BMS-986016 D1 240/80 CA224-020
- Melanom 010 Nivolumab + BMS-986016 kombi D1 480/160 CA224-020
- Melanom 011 Nivolumab + BMS-986016 kombi D1 240/80 CA224-020
- Melanom 012 Nivolumab + BMS-986016 kombi D2 480/160 CA224-020
- Melanom 013 Nivolumab + BMS-986016 kombi D2 480/240 CA224-020
- Melanom 015 Pembrolizumab (BGBIL006)
- Melanom 017, 018 CA224-020 Nivolumab+BMS-986016 kombi E1-E2
- Melanom 019 CA224-020 BMS-986213(nivo+relatlimab 480/160) armC
- Melanom 021 ONCOS C824 Syklofosfamid priming 300 mg/m2
- Melanom 022 ONCOS C824 Pembrolizumab 200 mg
- Melanom 029 Keynote 054 Pembrolizumab(MK-3475)/Placebo
- Melanom 030 GO42273 Atezolizumab -28, 1680 mg (arm 3)
- Melanom 031, 032 ABC-X
- Melanom 034-036 Tebentafusp
- Melanom 038-40 ATLAS-LYTIX (C20-315-05)
- Melanom 041 Ipilimumab 3 mg/nivolumab 1 mg
- Melanom 042-043 CA224-127 Nivolumab+Relatlimab FDC SC/IV
- Melanom 044-045 NeoLIPA LTX-315, pembrolizumab
Handlingsprogram Maligne melanomer
10.03.2023•Versjon 0.1
Handlingsprogram maligne melanomer
- Gå til avsnitt
- Handlingsprogram maligne melanomer
Lukk
